| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Thomas M Nappe, Christopher O Hoyt. Pediatric Death Due to Myocarditis After Exposure to Cannabis. Clinical practice and cases in emergency medicine. vol 1. issue 3. 2020-10-01. PMID:29849306. |
the authors report an 11-month-old male who, following cannabis exposure, presented with central nervous system depression after seizure, and progressed to cardiac arrest and died. |
2020-10-01 |
2023-08-13 |
Not clear |
| Manik Ahuja, Renee Cunningham-Williams, Kimberly B Werner, Kathleen K Buchol. Risk Factors Associated With Gambling Involvement among a National Sample of African American and European American Young Adults. Journal of substance abuse and alcoholism. vol 6. issue 3. 2020-10-01. PMID:30443591. |
current cannabis use was associated with all three categories among african americans, while current cigarette use was associated among european americans for lottery games, and depression (female) was associated with other games. |
2020-10-01 |
2023-08-13 |
human |
| Suzette Glasner, Frances Kay-Lambkin, Alan J Budney, Michael Gitlin, Bruce Kagan, Helene Chokron-Garneau, Alfonso Ang, Alexandra Venega. Preliminary Outcomes of a Computerized CBT/MET Intervention for Depressed Cannabis Users in Psychiatry Care. Cannabis (Research Society on Marijuana). vol 1. issue 2. 2020-10-01. PMID:31840135. |
although depression is common among cannabis users, there is a paucity of targeted interventions addressing depression and cannabis use disorders concurrently. |
2020-10-01 |
2023-08-13 |
human |
| Suzette Glasner, Frances Kay-Lambkin, Alan J Budney, Michael Gitlin, Bruce Kagan, Helene Chokron-Garneau, Alfonso Ang, Alexandra Venega. Preliminary Outcomes of a Computerized CBT/MET Intervention for Depressed Cannabis Users in Psychiatry Care. Cannabis (Research Society on Marijuana). vol 1. issue 2. 2020-10-01. PMID:31840135. |
feasibility, acceptability, perceived helpfulness, treatment retention, completion, and clinical outcomes including cannabis use and depression were assessed. |
2020-10-01 |
2023-08-13 |
human |
| Suzette Glasner, Frances Kay-Lambkin, Alan J Budney, Michael Gitlin, Bruce Kagan, Helene Chokron-Garneau, Alfonso Ang, Alexandra Venega. Preliminary Outcomes of a Computerized CBT/MET Intervention for Depressed Cannabis Users in Psychiatry Care. Cannabis (Research Society on Marijuana). vol 1. issue 2. 2020-10-01. PMID:31840135. |
participants found the shade intervention to be acceptable and helpful in facilitating action towards their therapeutic goals concerning depression and cannabis use. |
2020-10-01 |
2023-08-13 |
human |
| Lucy J Troup, Jeremy A Andrzejewski, Jacob T Braunwalder, Robert D Torrenc. The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado. PeerJ. vol 4. 2020-09-29. PMID:27957402. |
the relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in colorado. |
2020-09-29 |
2023-08-13 |
human |
| Lucy J Troup, Jeremy A Andrzejewski, Jacob T Braunwalder, Robert D Torrenc. The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado. PeerJ. vol 4. 2020-09-29. PMID:27957402. |
results indicate a relationship between casual cannabis use and scoring highly for depressive symptomatology on the center for epidemiologic studies depression scale. |
2020-09-29 |
2023-08-13 |
human |
| Alline C Campos, Manoela V Fogaça, Franciele F Scarante, Sâmia R L Joca, Amanda J Sales, Felipe V Gomes, Andreza B Sonego, Naielly S Rodrigues, Ismael Galve-Roperh, Francisco S Guimarãe. Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders. Frontiers in pharmacology. vol 8. 2020-09-29. PMID:28588483. |
beneficial effects of cannabidiol (cbd) have been described for a wide range of psychiatric disorders, including anxiety, psychosis, and depression. |
2020-09-29 |
2023-08-13 |
Not clear |
| Shawn Y Forrester, Nusrat Jaha. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus. vol 12. issue 4. 2020-09-28. PMID:32455076. |
escalating cannabis use may be linked to decreased motivation and anhedonia, which are symptoms of depression. |
2020-09-28 |
2023-08-13 |
human |
| Shawn Y Forrester, Nusrat Jaha. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus. vol 12. issue 4. 2020-09-28. PMID:32455076. |
the main issue regarding depression within the context of cannabis use is whether or not there is a neurobiological basis linking the two variables. |
2020-09-28 |
2023-08-13 |
human |
| Shawn Y Forrester, Nusrat Jaha. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus. vol 12. issue 4. 2020-09-28. PMID:32455076. |
data were included from studies that satisfied the following criteria: (i) published within the last 10 years (older studies were included based on relevance), (ii) on adolescent subjects (animal or human), (iii) published in english, (iv) journal articles, systematic reviews, meta-analyses, clinical trials, observational studies (animal or human), (v) on subjects who had unipolar depression with no comorbidities, and (vi) on subjects who used cannabis [with no confounding variables such as the use of ethanol, nicotine, cocaine, lysergic acid diethylamide (lsd), and heroin; and no medical conditions such as comorbid psychosis, mania, or autism]. |
2020-09-28 |
2023-08-13 |
human |
| Natalia Szejko, Carolin Fremer, Kirsten R Müller-Vah. Cannabis Improves Obsessive-Compulsive Disorder-Case Report and Review of the Literature. Frontiers in psychiatry. vol 11. 2020-09-28. PMID:32848902. |
here we present the case of a 22-year-old male patient, who suffered from severe ocd since childhood and significantly improved after treatment with medicinal cannabis with markedly reduced ocd and depression resulting in a considerable improvement of quality of life. |
2020-09-28 |
2023-08-13 |
Not clear |
| Rachel L Tomko, Nathaniel L Baker, Caitlyn O Hood, Amanda K Gilmore, Erin A McClure, Lindsay M Squeglia, Aimee L McRae-Clark, Susan C Sonne, Kevin M Gra. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology. vol 237. issue 2. 2020-08-04. PMID:31712969. |
depression is common among individuals with cannabis use disorder (cud), particularly individuals who present to cud treatment. |
2020-08-04 |
2023-08-13 |
Not clear |
| Jesse D Kosiba, Stephen A Maisto, Joseph W Ditr. Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social science & medicine (1982). vol 233. 2020-07-29. PMID:31207470. |
patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: systematic review and meta-analysis. |
2020-07-29 |
2023-08-13 |
Not clear |
| Jesse D Kosiba, Stephen A Maisto, Joseph W Ditr. Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social science & medicine (1982). vol 233. 2020-07-29. PMID:31207470. |
certifications for medical cannabis are generally restricted to a small number of specific medical conditions, yet patients frequently report symptoms of pain, anxiety, and depression as reasons for use. |
2020-07-29 |
2023-08-13 |
Not clear |
| Andrea Lukács, Małgorzata Wasilewska, Olha Sopel, Marie-Pierre Tavolacci, Beatrix Varga, Marta Mandziuk, Olena Lototska, Péter Sasvári, Halyna Krytska, Emőke Kiss-Tóth, Joël Ladne. Risk of eating disorders in university students: an international study in Hungary, Poland and Ukraine. International journal of adolescent medicine and health. 2020-06-18. PMID:32549156. |
students provided data about socioeconomic characteristics, body mass index (bmi), eds, physical fitness and sport practice, psychological distress (stress, anxiety, depression), life orientation, alcohol, tobacco, and cannabis use. |
2020-06-18 |
2023-08-13 |
human |
| Kei U Wong, Carl R Bau. Acute Cannabis Toxicity. Pediatric emergency care. vol 35. issue 11. 2020-04-28. PMID:31688799. |
exploratory or unintentional ingestions of cannabis-containing products (as opposed to those derived from synthetic cannabinoids, which may mimic the structure and/or function of cannabis, but are not the focus of this article) can lead to significant pediatric toxicity, including encephalopathy, coma, and respiratory depression. |
2020-04-28 |
2023-08-13 |
Not clear |
| Liat Shbiro, Danielle Hen-Shoval, Noa Hazut, Kayla Rapps, Shira Dar, Gil Zalsman, Raphael Mechoulam, Aron Weller, Gal Shova. Effects of cannabidiol in males and females in two different rat models of depression. Physiology & behavior. vol 201. 2020-04-27. PMID:30571957. |
effects of cannabidiol in males and females in two different rat models of depression. |
2020-04-27 |
2023-08-13 |
rat |
| Alexandra Butler, Karen A Patte, Mark A Ferro, Scott T Leatherdal. Interrelationships among depression, anxiety, flourishing, and cannabis use in youth. Addictive behaviors. vol 89. 2020-04-20. PMID:30321693. |
the objective of the study was to examine if depression or anxiety was associated with youth cannabis use; and investigate whether flourishing, an indicator of overall wellbeing, moderates these associations. |
2020-04-20 |
2023-08-13 |
Not clear |
| Bonnie J Leadbeater, Megan E Ames, Ashley N Linden-Carmichae. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. Addiction (Abingdon, England). vol 114. issue 2. 2020-03-23. PMID:30276906. |
age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. |
2020-03-23 |
2023-08-13 |
Not clear |